









市場
/
株式
/
nasdaq-blco
/

Bausch + Lomb Corp

BLCO

16.950USD

+0.050+0.30%

終値 12/19, 16:00（ET）15分遅れの株価

6.00B時価総額

損失額直近12ヶ月PER



Bausch + Lomb Corp

16.950

+0.050+0.30%

概要企業名金融分析

概要

企業名

金融

分析

詳細情報 Bausch + Lomb Corp 企業名

Bausch + Lomb Corporation is an eye health company. It operates through three segments: Vision Care, Pharmaceuticals, and Surgical. Vision Care segment includes both a contact lens and a consumer eye care business that consists of contact lens care products, over-the-counter eye drops and eye vitamins. Pharmaceuticals segment consists of generic pharmaceutical products for post-operative treatments and treatments for a number of eye conditions, such as glaucoma, eye inflammation, ocular hypertension, dry eyes and retinal diseases. Surgical segment consists of medical device equipment, consumables, instruments and technologies for the treatment of cataracts, corneal and vitreous and retinal eye conditions, which includes delivery systems, phacoemulsification equipment and other surgical instruments and devices for cataract surgery. Its brands consist of PreserVision, Biotrue, Artelac, Alaway, Mioclear, Ocuvite, ScoutPro, XIIDRA, Vyzulta, Lotemax, Prolensa, Minims, INFUSE, and many more.

Bausch + Lomb Corpの企業情報



企業コードBLCO

会社名Bausch + Lomb Corp

上場日May 06, 2022

最高経営責任者「CEO」Saunders (Brenton L)

従業員数13500

証券種類Ordinary Share

決算期末May 06

本社所在地520 Applewood Crescent

都市VAUGHAN

証券取引所NASDAQ OMX NASDAQ Basic NYSE

国Canada

郵便番号L4K 4B4

電話番号19082552864

ウェブサイトhttps://ir.bausch.com/

企業コードBLCO

上場日May 06, 2022

最高経営責任者「CEO」Saunders (Brenton L)

Bausch + Lomb Corpの経営陣



会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Brenton L. (Brent) Saunders, J.D.

Chairman of the Board, Chief Executive Officer

352.13K

+162.32%

Mr. Luc Bonnefoy

President - Surgical

77.36K

+8.63%

Dr. Yehia Hashad, M.D.

Executive Vice President - Research & Development, Chief Medical Officer

68.18K

+35.10%

Mr. Russel C. Robertson

Independent Director

66.56K

+2.53%

Dr. Andrew Charles Von Eschenbach, M.D.

Independent Director

62.09K

+55.01%

Mr. A. Robert D. Bailey, J.D.

Executive Vice President, Chief Legal Officer

Ms. Sarah B. Kavanagh

Independent Director

Mrs. Nathalie Bernier

Independent Director

Mr. Andrew J. Stewart

President - Global Pharmaceuticals and International Consumer

Mr. Sam A. Eldessouky

Chief Financial Officer, Executive Vice President

詳細を見る

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Brenton L. (Brent) Saunders, J.D.

Chairman of the Board, Chief Executive Officer

352.13K

+162.32%

Mr. Luc Bonnefoy

President - Surgical

77.36K

+8.63%

Dr. Yehia Hashad, M.D.

Executive Vice President - Research & Development, Chief Medical Officer

68.18K

+35.10%

Mr. Russel C. Robertson

Independent Director

66.56K

+2.53%

Dr. Andrew Charles Von Eschenbach, M.D.

Independent Director

62.09K

+55.01%

Mr. A. Robert D. Bailey, J.D.

Executive Vice President, Chief Legal Officer

収益内訳

通貨: USD更新時刻: Mon, Oct 6

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

事業別USD

会社名

収益

比率

OTC

482.00M

37.72%

Devices

472.00M

36.93%

Pharmaceuticals

260.00M

20.34%

Branded and other Generics

58.00M

4.54%

Other revenues

6.00M

0.47%

会社から関連データがまだ開示されていません。

事業別

地域別

事業別USD

会社名

収益

比率

OTC

482.00M

37.72%

Devices

472.00M

36.93%

Pharmaceuticals

260.00M

20.34%

Branded and other Generics

58.00M

4.54%

Other revenues

6.00M

0.47%

株主

更新時刻: Sat, Nov 22

株主統計

種類

株主統計

比率

Bausch Health Companies Inc

87.65%

Icahn Enterprises LP

0.99%

Deutsche Bank Securities Inc.

0.99%

Alberta Investment Management Corporation

0.92%

Oaktree Capital Management, L.P.

0.92%

他の

8.54%

株主統計

比率

Bausch Health Companies Inc

87.65%

Icahn Enterprises LP

0.99%

Deutsche Bank Securities Inc.

0.99%

Alberta Investment Management Corporation

0.92%

Oaktree Capital Management, L.P.

0.92%

他の

8.54%

種類

株主統計

比率

Corporation

87.66%

Hedge Fund

3.73%

Investment Advisor/Hedge Fund

3.07%

Research Firm

1.67%

Investment Advisor

1.65%

Holding Company

0.99%

Sovereign Wealth Fund

0.92%

Individual Investor

0.48%

Family Office

0.24%

機関投資家保有株



更新時刻: Mon, Dec 8

報告期間

機関投資家数

保有株式数

比率

変動額

2025Q4

247

42.63M

17.16%

+11.66K

2025Q3

260

42.62M

19.43%

+3.57M

2025Q2

253

39.09M

18.05%

+715.03K

2025Q1

249

38.33M

16.53%

-19.93M

2024Q4

239

35.61M

16.96%

-2.09M

2024Q3

234

37.72M

16.36%

-3.49M

2024Q2

237

40.61M

17.42%

+3.09M

2024Q1

226

37.49M

18.08%

-25.96M

2023Q4

216

38.90M

17.69%

-4.13M

2023Q3

198

43.02M

17.49%

-1.91M

詳細を見る

株主動向



会社名

保有株式数

比率

変動額

変動率

日付

Bausch Health Companies Inc

310.45M

87.68%

Mar 24, 2025

Deutsche Bank Securities Inc.

3.41M

0.96%

-89.90K

-2.57%

Jun 30, 2025

Alberta Investment Management Corporation

3.27M

0.92%

+258.00K

+8.58%

Mar 31, 2025

Oaktree Capital Management, L.P.

2.52M

0.71%

+2.52M

Jun 30, 2025

GoldenTree Asset Management, LP

2.58M

0.73%

+334.92K

+14.90%

Jun 30, 2025

D. E. Shaw & Co., L.P.

2.61M

0.74%

+728.68K

+38.79%

Jun 30, 2025

Fidelity Management & Research Company LLC

771.84K

0.22%

+771.84K

Jun 30, 2025

Glenview Capital Management, LLC

1.55M

0.44%

+1.05M

+210.77%

Jun 30, 2025

詳細を見る

配当金



過去5年間の配当金総支払額は 0.00 米ドルである。

日付

配当金

権利確定日

支払日

配当落ち日

データなし

株式分割



日付

種類

比率

データなし

日付

種類

比率

データなし

よくある質問

Bausch + Lomb Corpの上位5名の株主は誰ですか？



Bausch + Lomb Corpの上位5名の株主は以下のとおりです。
Bausch Health Companies Incは310.45M株を保有しており、これは全体の87.68%に相当します。
Deutsche Bank Securities Inc.は3.41M株を保有しており、これは全体の0.96%に相当します。
Alberta Investment Management Corporationは3.27M株を保有しており、これは全体の0.92%に相当します。
Oaktree Capital Management, L.P.は2.52M株を保有しており、これは全体の0.71%に相当します。
GoldenTree Asset Management, LPは2.58M株を保有しており、これは全体の0.73%に相当します。